Tags : Vela Diagnostics

PharmaShots Weekly Snapshot (November 04-08, 2019)

1. Triumvira’s TAC01-CD19 Receives FDA’s Fast Track Designation for R/R Diffuse Large B-Cell Lymphoma Published: Nov 07, 2019 | Tags: Triumvira, TAC01-CD19, Receives, FDA, Fast Track Designation, R/R, Diffuse Large B-Cell Lymphoma 2. Janssen Reports Submission of MAA to EMA for its Investigational Ebola Vaccine Regimen to Prevent Ebola Virus Disease Published: Nov 07, 2019 | Tags: […]Read More

Vela Diagnostics’ Sentosa SQ HIV-1 Genotyping Assay Receives the US

Shots: The novel HIV-1 Genotyping assay uses the plasma of patients infected with HIV-1 to detect HIV-1 Group M DRMs in the protease, reverse transcriptase, and integrase regions of the pol gene, in a single test Sentosa SQ HIV-1 Genotyping Assay is programmed on Sentosa NGS workflow enabling RNA extraction, PCR setup, library construction, template […]Read More